<?xml version="1.0"?>
<?xml-stylesheet type="text/css" href="https://wiki.dmt-nexus.me/w/skins/common/feed.css?303"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
		<id>https://wiki.dmt-nexus.me/w/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Hixidom</id>
		<title>DMT-Nexus Wiki - User contributions [en]</title>
		<link rel="self" type="application/atom+xml" href="https://wiki.dmt-nexus.me/w/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Hixidom"/>
		<link rel="alternate" type="text/html" href="https://wiki.dmt-nexus.me/Special:Contributions/Hixidom"/>
		<updated>2026-04-23T15:03:02Z</updated>
		<subtitle>User contributions</subtitle>
		<generator>MediaWiki 1.22.1</generator>

	<entry>
		<id>https://wiki.dmt-nexus.me/MDAI</id>
		<title>MDAI</title>
		<link rel="alternate" type="text/html" href="https://wiki.dmt-nexus.me/MDAI"/>
				<updated>2013-12-19T21:24:55Z</updated>
		
		<summary type="html">&lt;p&gt;Hixidom: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Safety_profile&lt;br /&gt;
|&lt;br /&gt;
* Entactogen, Empathogen, SSRA&lt;br /&gt;
|&lt;br /&gt;
* Entactogenic effects, Empathogenic effects, Euphoria&lt;br /&gt;
|&lt;br /&gt;
* Nausea, headache, tiredness, depression, rise in blood pressure&lt;br /&gt;
|&lt;br /&gt;
* Mental addiction. WARNING: Some studies have shown that much of what is sold online as &amp;quot;MDAI&amp;quot; actually contains mephedrone or other similar drugs.&lt;br /&gt;
|&lt;br /&gt;
* Cardiovascular toxicity has not been tested.  As of 2013, long-term studies on this substance have not been performed, so long term effects are still UNKNOWN!&lt;br /&gt;
}}&lt;br /&gt;
== Brief overview - What is MDAI? ==&lt;br /&gt;
&lt;br /&gt;
5,6-Methylenedioxy-2-aminoindane (MDAI) is a drug developed by David E. Nichols at Purdue University in the early 1990s. It is a highly selective serotonin releasing agent (SSRA).  Like MDA and MDMA, it produces entactogenic effects but, unlike similar drugs, it results in little to no stimulant effects.&lt;/div&gt;</summary>
		<author><name>Hixidom</name></author>	</entry>

	<entry>
		<id>https://wiki.dmt-nexus.me/MDAI</id>
		<title>MDAI</title>
		<link rel="alternate" type="text/html" href="https://wiki.dmt-nexus.me/MDAI"/>
				<updated>2013-12-19T21:24:13Z</updated>
		
		<summary type="html">&lt;p&gt;Hixidom: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Safety_profile&lt;br /&gt;
|&lt;br /&gt;
* Entactogen, Empathogen, SSRA&lt;br /&gt;
|&lt;br /&gt;
* Entactogenic effects, Empathogenic effects, Euphoria&lt;br /&gt;
|&lt;br /&gt;
* Nausea, headache, tiredness, depression, rise in blood pressure&lt;br /&gt;
|&lt;br /&gt;
* Mental addiction. WARNING: Some studies have shown that much of what is sold online as &amp;quot;MDAI&amp;quot; actually contains mephedrone and/or other drugs.&lt;br /&gt;
|&lt;br /&gt;
* Cardiovascular toxicity has not been tested.  As of 2013, long-term studies on this substance have not been performed, so long term effects are still UNKNOWN!&lt;br /&gt;
}}&lt;br /&gt;
== Brief overview - What is MDAI? ==&lt;br /&gt;
&lt;br /&gt;
5,6-Methylenedioxy-2-aminoindane (MDAI) is a drug developed by David E. Nichols at Purdue University in the early 1990s. It is a highly selective serotonin releasing agent (SSRA).  Like MDA and MDMA, it produces entactogenic effects but, unlike similar drugs, it results in little to no stimulant effects.&lt;/div&gt;</summary>
		<author><name>Hixidom</name></author>	</entry>

	<entry>
		<id>https://wiki.dmt-nexus.me/MDAI</id>
		<title>MDAI</title>
		<link rel="alternate" type="text/html" href="https://wiki.dmt-nexus.me/MDAI"/>
				<updated>2013-12-19T21:23:37Z</updated>
		
		<summary type="html">&lt;p&gt;Hixidom: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Safety_profile&lt;br /&gt;
|&lt;br /&gt;
* Entactogen, Empathogen, SSRA&lt;br /&gt;
|&lt;br /&gt;
* Entactogenic effects, Empathogenic effects, Euphoria&lt;br /&gt;
|&lt;br /&gt;
* Nausea, headache, tiredness, depression, rise in blood pressure&lt;br /&gt;
|&lt;br /&gt;
* Mental addiction. WARNING: Some studies have shown that much of what is sold online as &amp;quot;MDAI&amp;quot; actually contains other drugs such as mephedrone.&lt;br /&gt;
|&lt;br /&gt;
* Cardiovascular toxicity has not been tested.  As of 2013, long-term studies on this substance have not been performed, so long term effects are still UNKNOWN!&lt;br /&gt;
}}&lt;br /&gt;
== Brief overview - What is MDAI? ==&lt;br /&gt;
&lt;br /&gt;
5,6-Methylenedioxy-2-aminoindane (MDAI) is a drug developed by David E. Nichols at Purdue University in the early 1990s. It is a highly selective serotonin releasing agent (SSRA).  Like MDA and MDMA, it produces entactogenic effects but, unlike similar drugs, it results in little to no stimulant effects.&lt;/div&gt;</summary>
		<author><name>Hixidom</name></author>	</entry>

	<entry>
		<id>https://wiki.dmt-nexus.me/MDAI</id>
		<title>MDAI</title>
		<link rel="alternate" type="text/html" href="https://wiki.dmt-nexus.me/MDAI"/>
				<updated>2013-12-19T21:17:57Z</updated>
		
		<summary type="html">&lt;p&gt;Hixidom: /* Brief overview - What is MDAI? */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Safety_profile&lt;br /&gt;
|&lt;br /&gt;
* Entactogen, Empathogen, SSRA&lt;br /&gt;
|&lt;br /&gt;
* Entactogenic effects, Empathogenic effects, Euphoria&lt;br /&gt;
|&lt;br /&gt;
* Nausea, headache, tiredness, depression, rise in blood pressure&lt;br /&gt;
|&lt;br /&gt;
* Mental addiction&lt;br /&gt;
|&lt;br /&gt;
* Cardiovascular toxicity has not been tested.  As of 2013, long-term studies on this substance have not been performed, so long term effects are still UNKNOWN!&lt;br /&gt;
}}&lt;br /&gt;
== Brief overview - What is MDAI? ==&lt;br /&gt;
&lt;br /&gt;
5,6-Methylenedioxy-2-aminoindane (MDAI) is a drug developed by David E. Nichols at Purdue University in the early 1990s. It is a highly selective serotonin releasing agent (SSRA).  Like MDA and MDMA, it produces entactogenic effects but, unlike similar drugs, it results in little to no stimulant effects.&lt;/div&gt;</summary>
		<author><name>Hixidom</name></author>	</entry>

	<entry>
		<id>https://wiki.dmt-nexus.me/MDAI</id>
		<title>MDAI</title>
		<link rel="alternate" type="text/html" href="https://wiki.dmt-nexus.me/MDAI"/>
				<updated>2013-12-19T21:17:27Z</updated>
		
		<summary type="html">&lt;p&gt;Hixidom: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Safety_profile&lt;br /&gt;
|&lt;br /&gt;
* Entactogen, Empathogen, SSRA&lt;br /&gt;
|&lt;br /&gt;
* Entactogenic effects, Empathogenic effects, Euphoria&lt;br /&gt;
|&lt;br /&gt;
* Nausea, headache, tiredness, depression, rise in blood pressure&lt;br /&gt;
|&lt;br /&gt;
* Mental addiction&lt;br /&gt;
|&lt;br /&gt;
* Cardiovascular toxicity has not been tested.  As of 2013, long-term studies on this substance have not been performed, so long term effects are still UNKNOWN!&lt;br /&gt;
}}&lt;br /&gt;
== Brief overview - What is MDAI? ==&lt;br /&gt;
&lt;br /&gt;
5,6-Methylenedioxy-2-aminoindane (MDAI) is a drug developed by David E. Nichols at Purdue University in the early 1990s. It is a highly selective serotonin releasing agent (SSRA).  Like MDA and MDMA, it produces entactogenic effects.  Unlike similar drugs, it results in little to no stimulant effects.&lt;/div&gt;</summary>
		<author><name>Hixidom</name></author>	</entry>

	<entry>
		<id>https://wiki.dmt-nexus.me/MDAI</id>
		<title>MDAI</title>
		<link rel="alternate" type="text/html" href="https://wiki.dmt-nexus.me/MDAI"/>
				<updated>2013-12-19T21:13:33Z</updated>
		
		<summary type="html">&lt;p&gt;Hixidom: Added safety profile&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Safety_profile&lt;br /&gt;
|&lt;br /&gt;
* Entactogen, Empathogen, SSRA&lt;br /&gt;
|&lt;br /&gt;
* Entactogenic effects, Empathogenic effects, Euphoria&lt;br /&gt;
|&lt;br /&gt;
* Nausea, headache, tiredness, depression, rise in blood pressure&lt;br /&gt;
|&lt;br /&gt;
* Mental addiction&lt;br /&gt;
|&lt;br /&gt;
* Cardiovascular toxicity has not been tested.  As of 2013, elaborate studies on this substance have not been performed, so long term effects are still UNKNOWN!&lt;br /&gt;
}}&lt;br /&gt;
== Brief overview - What is MDAI? ==&lt;br /&gt;
&lt;br /&gt;
5,6-Methylenedioxy-2-aminoindane (MDAI) is a drug developed by David E. Nichols at Purdue University in the early 1990s. It is a highly selective serotonin releasing agent (SSRA).  Like MDA and MDMA, it produces entactogenic effects.  Unlike similar drugs, it results in little to no stimulant effects.&lt;/div&gt;</summary>
		<author><name>Hixidom</name></author>	</entry>

	</feed>